Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.04 USD | +5.70% | -1.45% | -38.74% |
Business Summary
Number of employees: 306
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Pharmaceutical Products
100.0
%
| 211 | 100.0 % | 257 | 100.0 % | +21.89% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 211 | 100.0 % | 257 | 100.0 % | +21.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 68 | 10-08-31 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 46 | 21-02-28 |
Chief Tech/Sci/R&D Officer | - | 21-11-30 | |
Rosh Dias
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-14 |
Karen Kotz
SAM | Sales & Marketing | - | 22-07-31 |
Paul Reider
PRN | Corporate Officer/Principal | 55 | 20-12-31 |
Corporate Officer/Principal | - | 14-04-27 | |
Corporate Officer/Principal | 57 | 21-12-16 | |
Rebecca Sunshine
HRO | Human Resources Officer | 61 | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Stolper
BRD | Director/Board Member | 52 | 21-01-04 |
Mats Wahlström
BRD | Director/Board Member | 70 | 11-12-31 |
Ali Satvat
BRD | Director/Board Member | 46 | 14-04-30 |
Lee Newcomer
BRD | Director/Board Member | 71 | 22-02-01 |
Denny Lanfear
CEO | Chief Executive Officer | 68 | 10-08-31 |
Georgia Erbez
BRD | Director/Board Member | 57 | Feb. 19 |
Director/Board Member | 68 | 22-05-17 | |
Michael Ryan
BRD | Director/Board Member | - | 23-07-17 |
Director/Board Member | 56 | 20-07-29 | |
Charles Newton
BRD | Director/Board Member | 53 | 22-05-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 113,498,415 | 108,865,391 ( 95.92 %) | 0 | 95.92 % |
Company contact information
Coherus BioSciences, Inc.
333 Twin Dolphin Drive Suite 600
94065, Redwood City
+650 649 3530
http://www.coherus.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.74% | 232M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CHRS Stock
- Company Coherus BioSciences, Inc.